Emera Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMA research report →
Range $52 – $52
Price Chart
About the company
Emera Incorporated, an energy and services company, invests in generation, transmission, and distribution of electricity in the United States, Canada, Barbados, and the Bahamas. The company operates through Florida Electric Utility, Canadian Electric Utilities, Gas Utilities and Infrastructure, Other Electric Utilities, and Other segments. It is involved in the purchase, transmission, distribution, and sale of natural gas; and physical energy marketing, trading, and other energy asset management activities.
- CEO
- Scott Balfour
- IPO
- 2010
- Employees
- 7,812
- HQ
- Halifax, NS, CA
Get TickerSpark's AI analysis on EMA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.85B
- P/E
- 22.54
- Fwd P/E
- 19.29
- PEG
- 2.88
- P/S
- 2.70
- P/B
- 1.52
- EV/EBITDA
- 15.03
- Div Yield
- 4.10%
- Gross Margin
- 13.48%
- Op Margin
- 15.97%
- Net Margin
- 12.85%
- ROE
- 7.51%
- ROIC
- 2.78%
Latest fiscal year · YoY change
- Revenue
- $8.30B+15.3%
- Gross Profit
- $2.04B-29.8%
- Op Income
- $1.55B
- Net Income
- $1.09B+91.9%
- EPS
- $3.39+98.2%
- OCF Growth
- -32.0%
- FCF Growth
- -242.3%
- 52W High
- $55.49
- 52W Low
- $45.77
- 50D MA
- $52.86
- 200D MA
- $51.09
- Beta
- 0.45
- RSI (14)
- 45
- Avg Volume
- 498.55K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Emera delivered in-line second-quarter adjusted EPS of $0.69, reinforced its growth outlook, and moved closer to a major portfolio reshaping with the approved New Mexico Gas sale.· August 7, 2026
- Q2 adjusted EPS was $0.69, with year-to-date adjusted EPS at $2.06, described as effectively consistent with last year.
- First-half adjusted earnings were $627 million, up $12 million year over year, and operating cash flow excluding working capital rose 8%.
- The New Mexico Gas sale was approved, with after-tax proceeds expected to be USD 650 million to USD 700 million in Q3 to help reduce holding company debt.
- Emera said it remains on track for compound annual adjusted EPS growth above its 5% to 7% target range through 2026 and expects growth within that range through 2030.
- Management highlighted a full-year capital plan of about $4 billion and 7% to 8% annual rate base growth through 2030.
Emera reported second-quarter adjusted EPS of $0.69, down $0.10 year over year, and second-quarter adjusted earnings of $212 million. Year-to-date adjusted earnings were $627 million, up $12 million from last year, and year-to-date adjusted EPS was $2.06, effectively flat versus last year. Operating cash flow excluding working capital increased 8% in the first half. Management said it expects after-tax proceeds of approximately USD 650 million to USD 700 million from the New Mexico Gas sale to be reflected in third-quarter results, and reiterated full-year capital deployment of approximately $4 billion. It continues to expect CAGR adjusted EPS growth above its 5% to 7% target range through 2026 and within that range through 2030, alongside targeted 7% to 8% annual rate base growth through 2030.
Scott Balfour focused on portfolio optimization, regulated utility growth, and large-scale infrastructure investment. He said the approved New Mexico Gas sale advances Emera’s strategy by strengthening the balance sheet and allowing more focus on higher-growth core regulated businesses, while also preserving investment capacity for customer service and reliability. His tone was constructive and confident, especially around Florida growth, data center opportunities, Nova Scotia electrification, and adjacency opportunities such as transmission projects in Atlantic Canada and Ontario.
Jared Green emphasized that first-half adjusted earnings of $627 million and 8% higher operating cash flow excluding working capital support the company’s credit profile and financial flexibility. He said Moody’s revised Emera’s credit outlook to stable and that the company remains on track to achieve Moody’s 12% operating cash flow pre-working capital to debt target in 2026, with the New Mexico Gas sale expected to add about 50 basis points on a sustained basis. He also noted the hybrid refinancing and a USD 300 million upsized hybrid issuance, plus year-to-date headwinds from a stronger Canadian dollar and a higher share count, each reducing adjusted EPS by $0.05.
Analysts focused on the balance sheet impact of the New Mexico Gas sale, with management saying the transaction should help push the company above Moody’s 12% CFO-to-debt threshold in calendar 2026 and provide some cushion, though Jared Green said he would prefer a bit more room over time. Questions also centered on Florida data center opportunities and the new large-load tariff; Scott Balfour said Senate Bill 484 gives clarity, protects existing customers from cost shifts, and could make large-load growth beneficial for rate pressure and investment. In Nova Scotia, management said discussions on thermal asset securitization remain on track for year-end, and they expressed increased federal engagement on Atlantic Canada transmission opportunities; they also said a U.S. redomicile is not being considered because of tax implications.
The call pointed to several supporting growth drivers: Florida customer growth, rate base investment, data center-related demand, and constructive regulatory developments. Management also sounded encouraged by the New Mexico Gas sale, the stable credit outlook, and a wider set of potential transmission opportunities in Atlantic Canada and Ontario. The company reiterated confidence in medium-term EPS and rate base growth targets.
Near-term earnings were not fully symmetrical, with Q2 adjusted EPS down $0.10 year over year and some segments facing higher depreciation, O&M, interest expense, and lower marketing and trading margins. Management also acknowledged a need to improve leverage cushion beyond the 12% Moody’s threshold over time, even after the New Mexico Gas sale. Regulatory and execution risk remains around the Nova Scotia securitization process, the Florida large-load tariff filing, and whether adjacent growth projects actually materialize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.6%
- Shares Outstanding
- 305.90M
- Float Shares
- 304.80M
Held by 26 ETFs
Biggest fund positions in EMA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 11, 07 | JONES GARY W | other | 500,000 |
| Jan 11, 07 | JONES GARY W | other | 32,500 |
| Jan 11, 07 | JONES GARY W | other | 44,435 |
| Jan 11, 07 | JONES GARY W | other | 15,254 |
| Jan 11, 07 | JONES GARY W | other | 9,152 |
| Jan 11, 07 | JONES GARY W | other | 9,152 |
| Jan 11, 07 | JONES GARY W | other | 78,000 |
| Jan 11, 07 | JONES GARY W | other | 22,750 |
| Jan 11, 07 | JONES GARY W | other | 11,700 |
| Jul 21, 06 | STILLWATER LLC | buy | 2,692,307 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EMA coverage
Recent articles, reports, and earnings notes.
No research on EMA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EMA report →Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
gurufocus.com · Aug 18
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
gurufocus.com · Aug 14
Bernhard Capital Partners Completes Acquisition of New Mexico Gas Company
prnewswire.com · Aug 12
Emera Completes Sale of New Mexico Gas Company
businesswire.com · Aug 12
Emera Q2 Earnings Call Highlights
marketbeat.com · Aug 9
Emera Reports 2026 Second Quarter Financial Results
businesswire.com · Aug 7
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
gurufocus.com · Aug 6
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
gurufocus.com · Aug 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.